These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6195116)

  • 1. Platelet thromboxane formation and BTG levels after intensive charcoal HP in uremics or regular hemodialytic treatment (RHT).
    Capodicasa G; Daví G; Picone F; Mattina A; Giannetto V; Vinti V; Vaccaro F; Strano A; De Santo NG; Giordano C
    Int J Artif Organs; 1983 Jul; 6(4):183-6. PubMed ID: 6195116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-thromboglobulin levels in chronic renal failure patients.
    Akizawa T; Nishiyama H; Koshikawa S
    Artif Organs; 1981 Feb; 5(1):54-8. PubMed ID: 6166286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
    Zatta A; Zanetti A; Dejana E; Prosdocimi M
    Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired platelet thromboxane production in renal failure.
    Smith MC; Dunn MJ
    Nephron; 1981; 29(3-4):133-7. PubMed ID: 7329487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of thromboxane B2 in uraemia and the effects of dialysis.
    Winter M; Frampton G; Bennett A; Machin SJ; Cameron JS
    Thromb Res; 1983 May; 30(3):265-72. PubMed ID: 6868024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of ticlopidine on the plasma levels of beta-thromboglobulin and thromboxane B2 in types 1 and 2 diabetics].
    Gragnoli G; Signorini AM; Tanganelli I
    Minerva Med; 1984 Jul; 75(30-31):1791-6. PubMed ID: 6207465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of platelet markers to evaluate membrane biocompatibility during a combined hemodialysis-hemoperfusion treatment.
    Buccianti G; Giaretto S; Pogliani EM; Lorenz M; Valenti G; Bianchi ML; Cresseri D
    Artif Organs; 1987 Oct; 11(5):416-20. PubMed ID: 2961320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmatic TXB2 and 6-keto-PGF1 alpha levels during charcoal hemoperfusion in chronic renal failure patients.
    Davì G; Orlandi M; Picone F; Galione G; Meringolo C; Mazzola A; Tomasi V; Capodicasa G; Strano A
    Prostaglandins Leukot Med; 1983 Mar; 10(3):309-17. PubMed ID: 6573692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-thromboglobulin in renal failure.
    Woo KT; Tan YO; Chong PY; Lau YK; Ng SL; Lim CH
    Aust N Z J Med; 1980 Oct; 10(5):581. PubMed ID: 6162446
    [No Abstract]   [Full Text] [Related]  

  • 13. [The level of thromboxane A2 and prostacyclin in patients with chronic kidney failure undergoing hemodialysis].
    Rud'ko IA; Kubatiev AA; Tsalenchuk IaP; Stel'makov BG
    Ter Arkh; 1991; 63(6):66-8. PubMed ID: 1948751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
    Kyrle PA; Stockenhuber F; Brenner B; Gössinger H; Korninger C; Pabinger I; Sunder-Plassmann G; Balcke P; Lechner K
    Thromb Haemost; 1988 Oct; 60(2):205-8. PubMed ID: 2975407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2 activity in platelets of patients with uremia.
    Vecino AM; Teruel JL; Navarro JL; Cesar JM
    Platelets; 2002 Nov; 13(7):415-8. PubMed ID: 12487789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
    Stefoni S; Feliciangeli G; Coli L; Scolari MP; Bonomini V
    Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane synthesis in hypercholesterolemic platelets--on the mechanism of increased thromboxane synthesis.
    Kawaguchi H
    Hokkaido Igaku Zasshi; 1983 May; 58(3):292-309. PubMed ID: 6618425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.